Abstract:Objective . Antimicrobial resistance has decreased eradication rates for Helicobacter pylori infection worldwide. To observe the effect of eradicating Helicobacter pylori (H. pylori) and the treatment of duodenal ulcer by 2 kinds of modified sequential therapy through comparing with that of 10-day standard triple therapy. Methods . A total of 210 patients who were confirmed in duodenal ulcer active or heal period by gastroscopy and H. pylori positive confirmed by rapid urease test, serum anti- H. pylori antibody (ELASE), or histological examination enrolled in the study. All the patients were randomly divided into three groups: group A (70 cases) and group B (70 cases) were provided 10-day modified sequential therapy; group C (70 cases) was provided 10-day standard triple therapy. Patients of group A received 20 mg of Esomeprazole, 500 mg of Clarithromycin for the first 5 days, followed by 20 mg of Esomeprazole, 500 mg of Clarithromycin, and 1000 mg of Amoxicillin for the remaining 5 days. Group B received 20 mg of Esomeprazole, 1000 mg of Amoxicillin for the first 5 days, followed by 20 mg of Esomeprazole, 500 mg of Clarithromycin, and 1000 mg of Amoxicillin for the remaining 5 days. Group C received 20 mg of Esomeprazole, 500 mg of Clarithromycin, and 1000 mg of Amoxicillin for standard 10-day therapy. All drugs were given twice daily. H. pylori eradication rate was checked four to eight weeks after taking the medicine by using a 13 C urea breath test. In the first, second, third, seventh, twenty-first, thirty-fifth days respectively, the symptoms of patients such as epigastric gnawing, burning pain, and acidity were evaluated simultaneously. Results . Overall, 210 patients accomplished all therapy schemes, 9 case patients were excluded. The examination result indicated that the H. pylori eradication rate of each group was as follows: group A 92.5% (62/67), group B 86.8% (59/68), and group C 78.8% (52/66). The H. pylori eradication rate of group A was slightly higher than group B ( P < 0.05 ) and both of them were obviously higher than group C ( P < 0.05 ). Modified sequential therapy was significantly more effective in patients with clarithromycin-resistant strains (80%/67% versus 31%; P = 0.02 ). Symptoms improvement: all the three groups could improve the symptoms such as epigastric gnawing, burning pain, and acidity since the first day. There was no significant difference in total score descending of symptoms between each group ( P > 0.05 ). Conclusions . All the three therapy schemes could alleviate symptoms of duodenal ulcer patients in China efficiently. But as far as eradicating H. pylori is concerned, the modified sequential therapy was better than standard triple therapy, especially the therapy scheme used in group A.

Efficacy of a 10-day sequential therapy for elimination of Helicobacter pylori infection

Efficacy of quadruple therapy with clarithromycin based on faecal molecular antimicrobial susceptibility tests as first-line treatment for <i>Helicobacter pylori</i> infection: a protocol of a single-centre, single-blind, randomised clinical trial in China

A 10-day sequential therapy for eradication of Helicobacter pylori infection in children]

Long-term Therapeutic Effect of Triple Therapy Consisted of Omeperazole,clarithromycin and Amoxycillin in Children with Helicobacter Pylori Infection and Approach to Re-Treatment after Failure of the Treatment

The Efficacy of Sequential Therapy and Standard Triple Therapy for Eradication of Helicobacter Pylori Infection in Children

Effect of 10-day Sequential Therapy Combined with Health Education on Patients with Helicobacter Pylori Eradica-tion Therapy Failure

Two-week Triple Therapy Has a Higher Helicobacter Pylori Eradication Rate Than 1-Week Therapy: A Single-Center Randomized Study

Clinical evaluation of four one-week triple therapy regimens in eradicating Helicobacter pylori infection.

Optimized sequential therapy vs 10- and 14-d concomitant therapy for eradicating Helicobacter pylori : A randomized clinical trial

Comparison of efficacy between sequential therapy and standard triple therapies for Helicobacter pylori infection

Is Short-Term Therapy Really Sufficient to Eradicate Helicobacter Pylori Infection?

Comparative Effectiveness And Tolerance Of Treatments For Helicobacter Pylori: Systematic Review And Network Meta-Analysis

A Multicentre Study on Eradication of Helicobacter Pylori Using Four 1-Week Triple Therapies in China.

Eradication Efficacy of Sequential Therapy Versus Standard Quadruple Therapy As Rescue Therapies for Failure of Helicobacter Pylori Eradication

Modified Sequential Therapy Regimen versus Conventional Triple Therapy for Helicobacter pylori Eradication in Duodenal Ulcer Patients in China: A Multicenter Clinical Comparative Study

Ten-Day Bismuth-Containing Quadruple Therapy is Effective As First-Line Therapy for Helicobacter Pylori-Related Chronic Gastritis: A Prospective Randomized Study in China

The Efficacy Observation of the 10 -Days Sequential Therapy in Remedy the Helicobacter Pylori Eradication Failure

Sequential, concomitant and hybrid first-line therapies for Helicobacter pylori eradication: a prospective randomized study

Efficacy of Omeprazole and Amoxicillin with Either Clarithromycin or Metronidazole on Eradication Ofhelicobacter Pyloriin Chinese Peptic Ulcer Patients

Different Duration of Quadruple Therapy for First-line Helicobacter Pylori Eradication Treatment——A Randomized,Controlled Trial

Efficacy of Triple Therapy and Sequential Therapy in the Eradication of Helicobacter Pylori in Patients Receiving Long-Term Non-Steroidal Anti-Inflammatory Drugs Treatment